Navigation Links
Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)
Date:12/8/2008

SAN FRANCISCO, Dec. 8 /PRNewswire/ -- Quantros, a leading provider of safety, quality, and compliance solutions for the healthcare industry, today announced that the Agency for Healthcare Research and Quality (AHRQ) has granted initial certification to Quantros Patient Safety Center as a Patient Safety Organization (PSO). The listing can be viewed at http://www.pso.ahrq.gov/listing/psolist.htm. The Quantros Patient Safety Center is a new division within Quantros that is specifically focused on review of safety processes, data analytics, and provision of associated knowledge content and complementary services to support healthcare providers using Quantros as a PSO to better address patient safety. Supporting healthcare providers in the improvement of safety and quality initiatives is in complete alignment with the mission and goals of the organization for more than nine years. Today more than 2,000 healthcare providers use one or more Quantros solutions for improving safety and quality within their care environment.

In addition to the Quantros Patient Safety Center, Quantros also supports other entities acting as a PSO with Quantros Patient Safety Organization (PSO) Manager, a streamlined, Web-based application that will enable PSOs to seamlessly aggregate required Common Format (CM) for event data as well as additional safety data for use as a confidential Patient Safety Work Product (PSWP). Just as with The Joint Commission ORYX Core Measures program, Quantros has chosen to act as both a technology provider and a PSO.

Dr. Sanjaya Kumar, Quantros President and CEO commented, "Quantros is in business to assist healthcare providers in advancing safety and quality improvement initiatives. The Quantros Patient Safety Center was created to further that cause for healthcare providers who want to leverage both Quantros and associated partner expertise. In addition, PSO vendors utilizing Quantros PSO Manager can avail of the services and content infrastructure and make that available to their members."

The Quantros Patient Safety Center will provide complete support per the PSO regulations including the aggregation, protection and dissemination of information including submissions and comparative reports via the Network of Patient Safety Databases (NPSD) as well as the aggregated, PHI de-identified Quantros Patient Safety Center data repository. This new division will provide a host of clinically-based services and analysis specifically designed for improving safety within the healthcare environment.

Additional information concerning the Quantros Patient Safety Center can be viewed at http://www.quantros.com/qpsc.

About Quantros

Quantros provides real-time solutions for safety and risk management, outcomes and performance monitoring, accreditation and compliance, and surveillance and decision support for leading healthcare providers throughout the nation. Quantros' web delivered applications provide a standard platform that creates actionable knowledge that helps its clients save lives, improve quality, and conserve assets. Through a variety of direct sales and vendor partners, more than 2,000 healthcare facilities use Quantros' web-based technology solutions every day.

Quantros team members include physicians, nurses and healthcare professionals as well as an experienced team of information technology specialists. Visit Quantros on the web at http://www.quantros.com.


'/>"/>
SOURCE Quantros
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
2. Quantros Expanding Support for Alternative Web Browsers
3. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
4. Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial
5. Electronic Prescribing Saves Patients Money
6. Confusing risk information may lead breast cancer patients to make poor treatment choices
7. Marital problems lead to poorer outcomes for breast cancer patients
8. Vitamin B1 could reverse early-stage kidney disease in diabetes patients
9. Lenalidomide safe as single therapy for elderly CLL patients
10. Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets.
11. CHOC Childrens Draws First Patient Dose With RIVA System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... ... ... With less than 10,000 dermatologists in the United States and more than ... the desire to conquer breakouts and eliminate skincare stress is widespread. Curology , ... released its inaugural survey on the State of Acne in America. , The ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency ... in early March. , The seed processing plant opened in Marshallville in 2006, and ... The new office allows opportunity for transition of Patten Seed operations to the Middle ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that ... Donald Quinn. , “There were things that his parents and teachers had asked of him ... way that he was going to defy the Almighty Creator. There were some who would ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... New York , March 28, 2017 ... a largely consolidated vendor landscape, with the top three ... Agilent Technologies accounting for a significant 49% of the ... a recent report. The vendor landscape is intensely competitive ... share in the overall market. These factors have restricted ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... 2017  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a ... and other unmet medical needs, announced today two ... Research annual meeting.  The first poster to be ... of ENMD-2076 in Combination with Anti-PD1 in Syngeneic ... be presented on April 4 is entitled " ...
Breaking Medicine Technology: